I wouldn't be surprised if the buy and sell side was being controlled by the same person.Let's hope we can see some news tomorrow and finally see glm return to half the issue price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025